We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

51 hedge funds and large institutions have $197M invested in Galera Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 8

16% more capital invested

Capital invested by funds: $170M → $197M (+$27.3M)

16% more funds holding

Funds holding: 44 → 51 (+7)

Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
+$9.47M
2
FM
Frazier Management
Washington
+$2.64M
3
CCM
CAAS Capital Management
New York
+$1.95M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
5
BlackRock
BlackRock
New York
+$1.25M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$7.46M
2
NHAS
Novo Holdings A/S
Denmark
-$4.92M
3
WMSA
Weiss Multi-Strategy Advisers
New York
-$405K
4
TRCT
Tower Research Capital (TRC)
New York
-$73.6K
5
Northern Trust
Northern Trust
Illinois
-$56.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$44.6M – – –
SI
2
Sofinnova Investments
California
$31.5M – – –
NHAS
3
Novo Holdings A/S
Denmark
$30.3M -$4.92M -450,000 -13%
Blackstone Inc
4
Blackstone Inc
New York
$17.2M – – –
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$15.4M – – –
TCM
6
Tekla Capital Management
Massachusetts
$10.7M – – –
VA
7
VR Adviser
New York
$9.39M +$9.47M +866,207 +1,677%
RSCM
8
Rock Springs Capital Management
Maryland
$5.81M – – –
BlackRock
9
BlackRock
New York
$5.49M +$1.25M +114,325 +27%
Vanguard Group
10
Vanguard Group
Pennsylvania
$5.13M +$1.47M +134,366 +37%
SFM
11
Sphera Funds Management
Israel
$4.78M -$17.3K -1,583 -0.3%
PA
12
Perceptive Advisors
New York
$3.33M – – –
FM
13
Frazier Management
Washington
$2.46M +$2.64M +241,000 New
CCM
14
CAAS Capital Management
New York
$1.82M +$1.95M +178,141 New
State Street
15
State Street
Massachusetts
$1.24M +$420K +38,369 +46%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.16M +$132K +12,110 +12%
Northern Trust
17
Northern Trust
Illinois
$1.01M -$56.7K -5,182 -5%
TWMP
18
Taylor Wealth Management Partners
Massachusetts
$662K +$28.2K +2,582 +4%
Millennium Management
19
Millennium Management
New York
$411K +$135K +12,317 +44%
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
$358K -$678 -62 -0.2%
Wells Fargo
21
Wells Fargo
California
$354K +$304K +27,796 +408%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$351K +$111K +10,142 +42%
PAM
23
Panagora Asset Management
Massachusetts
$345K +$361K +33,042 +4,796%
WMSA
24
Weiss Multi-Strategy Advisers
New York
$315K -$405K -37,034 -55%
RJFSA
25
Raymond James Financial Services Advisors
Florida
$292K – – –
1
2 3

GRTX Hedge Fund Activity: Q4 2020 in Review

51 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q4 2020, worth a combined $197M — up 16% from $170M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new GRTX positions and 1 closed out — a net gain of 7 holders — while 20 added to existing stakes and 8 trimmed.

The largest buyer was VR Adviser, adding an estimated $9.47M. The largest seller was RA Capital Management, exiting entirely with an estimated $7.46M sold.

  • 51 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q4 2020, up from 44 in Q3 2020.
  • Funds reported $197M of Galera Therapeutics, Inc. Common Stock stock for Q4 2020, up 16% quarter-over-quarter.
  • 8 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q4 2020 and 1 closed out, a net change of +7 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q4 2020 was VR Adviser, an estimated $9.47M added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q4 2020 was RA Capital Management, an estimated $7.46M sold.

Based on aggregated 13F filings for Q4 2020.